424B5
Offering supplement
✓ VerifiedRocket Lab's prospectus supplement documents its at-the-market program for up to $3,000,000,000 of common stock, including forward sales, with the stock last at $131.16.
Filed May 20, 2026 · 17:23 ET
Summary
- The supplement covers sales of up to $3,000,000,000 through a sixteen-bank agent group, with forward transactions available.
- Forward sellers earn a commission not to exceed 2.0% of the volume weighted average price of borrowed shares sold.
- The stock last traded at $131.16 on May 18, 2026.
Key facts
- Program size
- up to $3,000,000,000
From the filing for Program size
“Rocket Lab Corporation Up to $3,000,000,000 Common Stock”
- Reference price
- $131.16
From the filing for Reference price
“the last reported sale price of our common stock was $131.16 per share”
Why it mattersA $3 billion shelf at $131 is the currency that made the Iridium bid credible weeks later.
- Filed
- May 20, 2026
- Accepted
- 2026-05-20 21:23Z
- Accession no.
- 0001819994-26-000044
- Size
- 707 KB
- Index
- Filing index